Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis BYao‐Chun Hsu, Mindie H. Nguyen, Norihiro Furusyo et al.|The American Journal of Gastroenterology|2019Cited by 102
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis BYao‐Chun Hsu, Mindie H. Nguyen, Ming‐Lun Yeh et al.|The Journal of Infectious Diseases|2021Cited by 87
Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in TaiwanChi‐Yi Chen, Ming‐Lung Yu, Chung‐Feng Huang et al.|Liver International|2021Cited by 57
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patientsMatt Liu, Jia‐Horng Kao, Tai‐Chung Tseng et al.|Hepatology International|2021Cited by 33
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Chung‐Feng Huang, Ming‐Lung Yu, Kuo‐Chih Tseng et al.|Clinical Gastroenterology and Hepatology|2021Cited by 32